Showing results (631-640 of 677) with videos related to
Sort By:
Pageof 68
International Immunopharmacology|January 23, 2022
Exogenous pancreatic kininogenase protects against tacrolimus-induced renal injury by inhibiting PI3K/AKT signaling: The role of bradykinin receptorsJun Ding, Jian Jin, Yan Na Lei, et al.Scientific Reports|June 29, 2026
Perception and knowledge of Fabry disease: a comparative survey of patients and medical professionals in South KoreaSoo Jeong Choi, Su Hyun Kim, Semin Cho, et al.Plos One|December 22, 2017
Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipientsMyeong Hee Kim, Yu Ho Lee, Jung-Woo Seo, et al.Frontiers in Immunology|June 28, 2021
Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney TransplantationJung-Woo Seo, Yu Ho Lee, Dong Hyun Tae, et al.Journal of Patient-Reported Outcomes|December 16, 2022
Patients' self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational studySung-Hoo Hong, Ho Seok Chung, Ill-Young Seo, et al.Transplantation Proceedings|November 17, 2019
Long-term Trends in the Clinicopathologic Features of Kidney Transplant Recipients With Graft DysfunctionYu Ho Lee, Jung Jun Lee, So-Young Lee, et al.Acta Pharmacologica Sinica|June 20, 2020
L-Carnitine protects against tacrolimus-induced renal injury by attenuating programmed cell death via PI3K/AKT/PTEN signalingHai-Lan Zheng, Hai-Yue Zhang, Chun-Lian Zhu, et al.Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.Plos One|June 13, 2023
The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1/JNK/p38 MAPK-mediated apoptosis in unilateral ureteral obstructionJun Ding, Sheng Cui, Song Yu Li, et al.Blood Advances|July 3, 2023
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFcJulie O'Neal, Matthew L Cooper, Julie K Ritchey, et al.Pageof 68